Evidence map›Paper›PMID 31941691›Full record

ArticleJournal of clinical microbiology2020

Prospective Evaluation of the mariPOC Test for Detection of Clostridioides difficile Glutamate Dehydrogenase and Toxins A/B.

Roosa Savolainen, Juha M Koskinen, Silja Mentula, Janne O Koskinen, Suvi-Sirkku Kaukoranta

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Emerging Diagnostics inInternational journal of molecular sciences · 2024
    Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Roosa Savolainen *Department of Clinical Microbiology, Vaasa Central Hospital, Vaasa, Finland roosa.savolainen@vshp.fi juha.koskinen@arcdia.com.
Juha M Koskinen *ArcDia International Ltd., Turku, Finland roosa.savolainen@vshp.fi juha.koskinen@arcdia.com.ORCID 0000-0002-0746-7389
Silja MentulaExpert Microbiology Unit, National Institute for Health and Welfare, Helsinki, Finland.
Janne O KoskinenArcDia International Ltd., Turku, Finland.
Suvi-Sirkku KaukorantaDepartment of Clinical Microbiology, Vaasa Central Hospital, Vaasa, Finland.
University of Turku · FIVaasa Central Hospital · FIFinnish Institute for Health and Welfare · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective of this study was to evaluate a novel automated random-access test, mariPOC CDI (ArcDia Ltd., Finland), for the detection of

Indexed as

Bacterial ToxinsClostridioides difficileClostridium InfectionsBacterial ProteinsClostridioidesEnterotoxinsFecesFinlandGlutamate DehydrogenaseHumansProspective StudiesSensitivity and SpecificityBacterial ProteinsBacterial ToxinsEnterotoxinsGlutamate Dehydrogenaseacute gastroenteritisCDIClostridioides difficileClostridium difficilediagnosticsgastrointestinal infectionGDHglutamate dehydrogenasemariPOCtoxin A/B

Identifiers

PMID31941691
PMCPMC7098770
OpenAlexW3000579776

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.